Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concentrated safety monitoring study of Xuesaitong TCM Injection
ChiCTR-OCS-14004593Phase 4Completed
- Sponsor
- Tianjin TCM Institute of Clinical Evaluation
- Start
- May 2014
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Xuesaitong TCM Injection in adverse drug reaction (ADR), sponsored by Tianjin TCM Institute of Clinical Evaluation. Primary endpoint: Safety indexes. Started May 2014; status: completed.
02
Drugs
Xuesaitong TCM Injection
03
Conditions
adverse drug reaction (ADR)
Beyond the preview
Go deeper on ChiCTR-OCS-14004593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OCS-14004593.